Conning Inc. Amgen Inc Transaction History

Conning Inc.

$2.89 Billion
Q3 2024

A detailed history of Conning Inc. transactions in Amgen Inc stock. As of the latest transaction made, Conning Inc. holds 4,834 shares of AMGN stock, worth $1.39 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,834

Previous 4,031 19.92%

Holding current value

$1.39 Million

Previous $1.26 Million 23.67%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $248,432 - $270,916	803 Added 19.92%	4,834 $1.56 Million
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $24,173 - $29,376	92 Added 2.34%	4,031 $1.26 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $22,853 - $27,587	-85 Reduced 2.11%	3,939 $1.12 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 0.25%	4,024 $1.16 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $8,746 - $10,858	40 Added 1.0%	4,034 $1.08 Million
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $31.1 Million - $36.8 Million	-145,325 Reduced 97.33%	3,994 $886,000
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $4.08 Million - $4.97 Million	18,059 Added 13.76%	149,319 $36.1 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $3.57 Million - $4.53 Million	-15,578 Reduced 10.61%	131,260 $34.5 Million
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $7.03 Million - $7.93 Million	-31,338 Reduced 17.59%	146,838 $33.1 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $4.71 Million - $5.24 Million	-20,422 Reduced 10.28%	178,176 $43.3 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $9.71 Million - $10.7 Million	-44,267 Reduced 18.23%	198,598 $48 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $2.9 Million - $3.32 Million	14,577 Added 6.39%	242,865 $54.6 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $1.96 Million - $2.3 Million	9,230 Added 4.21%	228,288 $48.5 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $332,384 - $368,756	1,423 Added 0.65%	219,058 $53.4 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $891,856 - $1.04 Million	4,019 Added 1.88%	217,635 $54.2 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $7.98 Million - $9.51 Million	36,902 Added 20.88%	213,616 $49.1 Million
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $1.59 Million - $1.77 Million	-6,782 Reduced 3.7%	176,714 $44.9 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $6.96 Million - $8.54 Million	-35,200 Reduced 16.1%	183,496 $43.3 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $2.23 Million - $2.96 Million	12,259 Added 5.94%	218,696 $44.3 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $1.04 Million - $1.34 Million	-5,517 Reduced 2.6%	206,437 $49.8 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $5.61 Million - $6.72 Million	-32,207 Reduced 13.19%	211,954 $41 Million
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $1.44 Million - $1.69 Million	8,627 Added 3.66%	244,161 $45 Million
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $1.92 Million - $2.16 Million	10,601 Added 4.71%	235,534 $44.7 Million
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $2.7 Million - $3.15 Million	-15,142 Reduced 6.31%	224,933 $43.8 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $1.36 Million - $1.53 Million	-7,345 Reduced 2.97%	240,075 $49.8 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $1.51 Million - $1.69 Million	9,074 Added 3.81%	247,420 $45.7 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $3.8 Million - $4.44 Million	22,449 Added 10.4%	238,346 $40.6 Million
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $1.31 Million - $1.47 Million	7,773 Added 3.73%	215,897 $37.5 Million
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $34.8 Million - $39.8 Million	208,124	208,124 $38.8 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account